KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced that data on PV-10 for metastatic melanoma will be presented at the ESMO 2012 (European Society for Medical Oncology) Congress in Vienna, Austria on October 1, 2012.
